HCCC News and Press, H/Cell Energy Corp From 02/12/22

Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports and conference presentatio...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Alpha Tau Announces New Research Collaboration to Study the Potential of Alpha DaRT to Enhance Immune Stimulation in the Treatment of Breast Cancer PR Newswire JERUSALEM , Jan. 20, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of t...

Alpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer Alpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer PR Newswire JERUSALEM , Jan. ...

Alpha Tau Announces Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®) PR Newswire JERUSALEM , Nov. 3, 2021 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radi...

Alpha Tau Announces Completion of Enrollment in First US Clinical Trial of Alpha DaRT™ and Achievement of First Primary Objective PR Newswire JERUSALEM , Oct. 25, 2021 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative al...

Welbilt receives a second more lucrative offer from the Ali Group that is well above the current all-stock deal with Middleby. Regulatory agencies flex their muscles with China’s antitrust regulator blocking Tencent Holdings’ plan to merge Huya and DouYu. EU approves...

Dzmitry Dzemidovich/iStock via Getty Images Alpha Tau Medical Limited is planning a listing on Nasdaq after the oncology therapeutics company entered into a business combination agreement with special purpose acquisition company Healthcare Capital Corp ([[HCCC]] +2.1%). The closing ...

Wilmington, DE, March 04, 2021 (GLOBE NEWSWIRE) -- Healthcare Capital Corp. (the “ Company ”) announced today that, commencing March 8, 2021, holders of the 27,500,000 units sold in the Company’s initial public offering may elect to separately trade the Company&...

JERSEY CITY, N.J., Oct. 05, 2020 (GLOBE NEWSWIRE) -- H/Cell Energy Corporation (OTCQB-HCCC) (the “Company”), a company that focuses on the production of hydrogen for clean energy applications, has announced several restructuring changes in order to take advantage of the hydrog...